Co-Quetiapine 100 mg
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety, Contamination
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
| Lot or serial number | Brand name | Companies | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| More than 10 numbers, contact manufacturer. | A. Co-Quetiapine 100 mg | - Recalling Firm
- Cobalt Pharmaceuticals Inc.
- 6500 Kitimat Road,
- Mississauga
- L5N 2B8
- Ontario
- CANADA
- Marketing Authorization Holder
- Cobalt Pharmaceuticals Inc.
- 6500 Kitimat Road,
- Mississauga
- L5N 2B8
- Ontario
- CANADA
| Tablets | DIN 02316099 | 100 mg / tablet |
Recalled products
-
Co-Quetiapine 100 mg
Potential cross-contamination of trace amounts of Clindamycin in Quetiapine Active Pharmaceutical Ingredient during the manufacturing process.
Product distributed to wholesalers and pharmacies across Canada